Work

Спорные вопросы лечения анемии у больных с ХБП. Новые возможности

Year: 2023
Type: article
Abstract: The presented article reflects the actual problem of anemia treatment in patients with chronic kidney disease. Discussed controversial approaches to the therapy of anemia with iron preparations and erythropoietin-stimulating agents (ESS). For the first time, the critical assessment of clinical recommendations and treatment results was given. Reflected the issues of resistance to ESS are considered, the factors leading to this condition, the role of iron is shown. New information about hypoxia–induced factor (HIF) activator drugs is presented, the role of these drugs in the treatment of anemia in patients with CKD is shown. Provided the researches devoted to the first drug of this class – roxadustate.
Language: Russian
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W7168437662
FWCI:
Cites: 50
Cited by:
Related to: 10